-+ 0.00%
-+ 0.00%
-+ 0.00%

EVOTEC AND BRISTOL MYERS SQUIBB ADVANCE STRATEGIC PROTEIN DEGRADATION PARTNERSHIP WITH SECOND IND ACCEPTANCE

Reuters·11/19/2026 07:09:05